PharmaCytics is een Farma bedrijf dat innovatieve technologie om de werking van medicijnen te verbeteren ontwikkelt. Daarnaast verricht PharmaCytics onderzoek naar nieuwe therapieën voor therapeutische gebieden die raakvlakken hebben met het thema Absorptie & Metabolisme, zoals kanker, diabetes, infectieziekten en ouderdom gerelateerde aandoeningen.
PharmaCytics Operations BV
Novio Tech Campus, Office 3.12, Transistorweg 5v, 6534 AT Nijmegen, The Netherlands
PharmaCytics is a pharmaceutical Research company, specialized in synthetic chemistry, and produces bioactive molecules to study and manipulate biological systems. The company has extensive expertise on medicinal chemistry and drug delivery, with emphasis on advanced prodrug technology.
We are a team of scientists and business experts, highly motivated to develop new and value-added therapies to relieve medical issues of patients. Our focus is to provide innovative solutions for drug delivery by facilitating transport of biomolecules through cellular membranes. By combining knowledge of cellular processes with medicinal chemistry expertise, we have developed proprietary technology to solve absorption problems of (oral) medication by exploiting the high transport capacity of specific carrier proteins. Furthermore, we are performing a feasibility study for our oncology programs to exploit transporter proteins in the membrane of tumor cells to develop enhanced anti-cancer medication.
PharmaCytics was founded in November 2011. The company has its headquarters in Schaijk, The Netherlands and has very recently moved into its new Research facilities at the Novio Tech Campus in Nijmegen.